A selective novel low‐molecular‐weight inhibitor of IκB kinase‐β (IKK‐β) prevents pulmonary inflammation and shows broad anti‐inflammatory activity
Open Access
- 1 May 2005
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 145 (2) , 178-192
- https://doi.org/10.1038/sj.bjp.0706176
Abstract
1 Pulmonary inflammatory diseases such as asthma are characterized by chronic, cell‐mediated inflammation of the bronchial mucosa. 2 Recruitment and activation of inflammatory cells is orchestrated by a variety of mediators such as cytokines, chemokines, or adhesion molecules, the expression of which is regulated via the transcription factor nuclear factor kappa B (NF‐κB). 3 NF‐κB signaling is controlled by the inhibitor of kappa B kinase complex (IKK), a critical catalytic subunit of which is IKK‐β. 4 We identified COMPOUND A as a small‐molecule, ATP‐competitive inhibitor selectively targeting IKK‐β kinase activity with a Ki value of 2 nM. 5 COMPOUND A inhibited stress‐induced NF‐κB transactivation, chemokine‐, cytokine‐, and adhesion molecule expression, and T‐ and B‐cell proliferation. 6 COMPOUND A is orally bioavailable and inhibited the release of LPS‐induced TNF‐α in rodents. 7 In mice COMPOUND A inhibited cockroach allergen‐induced airway inflammation and hyperreactivity and efficiently abrogated leukocyte trafficking induced by carrageenan in mice or by ovalbumin in a rat model of airway inflammation. 8 COMPOUND A was well tolerated by rodents over 3 weeks without affecting weight gain. 9 Furthermore, in mice COMPOUND A suppressed edema formation in response to arachidonic acid, phorbol ester, or edema induced by delayed‐type hypersensitivity. 10 These data suggest that IKK‐β inhibitors offer an effective therapeutic approach for inhibiting chronic pulmonary inflammation. British Journal of Pharmacology (2005) 145, 178–192. doi:10.1038/sj.bjp.0706176Keywords
This publication has 64 references indexed in Scilit:
- IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesisNature, 2004
- IKK2 Inhibitor Alleviates Kidney and Wasting Diseases in a Murine Model of Human AIDSThe American Journal of Pathology, 2004
- Specific Inhibition of IκB Kinase Reduces Hyperalgesia in Inflammatory and Neuropathic Pain Models in RatsJournal of Neuroscience, 2004
- Mechanisms of severe asthmaClinical and Experimental Allergy, 2003
- Update on glucocorticoid action and resistanceJournal of Allergy and Clinical Immunology, 2003
- Activation and Localization of Transcription Factor, Nuclear Factor- κ B, in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Recombinant IκB Kinases α and β Are Direct Kinases of IκBαJournal of Biological Chemistry, 1998
- The Allergen Der p1 Induces NF-kB Activation through Interference with IkBα Function in Asthmatic Bronchial Epithelial CellsBiochemical and Biophysical Research Communications, 1997
- Nuclear Factor kB Is Activated by Arachidonic Acid but Not by Eicosapentaenoic AcidBiochemical and Biophysical Research Communications, 1996
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994